A phase 2 pilot study of umbilical cord blood infusion as an adjuvant consolidation therapy in elderly patients with acute myeloid leukemia

Abstract Acute myeloid leukemia (AML) is an aging-related malignancy, with patients aged ≥60 years old facing significantly poorer prognosis. Umbilical cord blood (UCB) has emerged as a promising source with effective anti-aging roles. Here, we conducted a prospective, phase 2, single-arm trial of U...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Jinzeng Wang, Xiaoyang Li, Ping Liu, Yao Dai, Hongming Zhu, Yunxiang Zhang, Min Wu, Yunying Yao, Mingzhu Liu, Shuting Yu, Fangying Jiang, Shuai Wang, Haoran Mu, Bo Jiao, Hua Yan, Wen Wu, Yang Shen, Junming Li, Shengyue Wang, Ruibao Ren
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Nature Publishing Group 2024-12-01
Seri Bilgileri:	Signal Transduction and Targeted Therapy
Online Erişim:	https://doi.org/10.1038/s41392-024-02065-y
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

A phase 2 pilot study of umbilical cord blood infusion as an adjuvant consolidation therapy in elderly patients with acute myeloid leukemia

Benzer Materyaller